Dr. Domenica Lorusso
Claim this profileFondazione Policlinico Universitario Agostino Gemelli IRCCS
Area of expertise
Ovarian Cancer
Domenica Lorusso has run 6 trials for Ovarian Cancer. Some of their research focus areas include:
Cancer
Domenica Lorusso has run 4 trials for Cancer. Some of their research focus areas include:
Clinical Trials Domenica Lorusso is currently running
PC14586
for Solid Tumors
This trial is testing a new oral drug, PC14586 (rezatapopt), alone and with pembrolizumab, in patients with advanced cancers that have a specific genetic mutation. The drug aims to fix a mutated protein to help control cancer growth. The study will determine the best dose and evaluate the drug's safety and effectiveness.
Recruiting
1 award
Phase 1 & 2
5 criteria
CPI-0209
for Cancer and Lymphoma
The purpose of this open-label, first-in-human (FIH) trial is to evaluate the safety, tolerability, and preliminary clinical activity of Tulmimetostat as a monotherapy in patients with advanced solid tumors and lymphomas.
Recruiting
1 award
Phase 1 & 2
8 criteria
More about Domenica Lorusso
Clinical Trial Related
6 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Domenica Lorusso has experience with
- Paclitaxel
- Topotecan
- Bevacizumab
- Tisotumab Vedotin
- Pembrolizumab
- Atezolizumab
Breakdown of trials Domenica Lorusso has run
Ovarian Cancer
Cancer
Cervical Cancer
Endometrial Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Domenica Lorusso specialize in?
Domenica Lorusso focuses on Ovarian Cancer and Cancer. In particular, much of their work with Ovarian Cancer has involved Stage IV patients, or patients who are ARID1A positive.
Is Domenica Lorusso currently recruiting for clinical trials?
Yes, Domenica Lorusso is currently recruiting for 4 clinical trials in Roma RM. If you're interested in participating, you should apply.
Are there any treatments that Domenica Lorusso has studied deeply?
Yes, Domenica Lorusso has studied treatments such as Paclitaxel, Topotecan, Bevacizumab.
What is the best way to schedule an appointment with Domenica Lorusso?
Apply for one of the trials that Domenica Lorusso is conducting.
What is the office address of Domenica Lorusso?
The office of Domenica Lorusso is located at: Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, RM 00168 Italy. This is the address for their practice at the Fondazione Policlinico Universitario Agostino Gemelli IRCCS.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.